Prot# A3921050: A Phase 2, Multicenter, Open-Label, Active Comparator-Controlled, Extension Trial to Evaluate the Long-Term Safety and Efficacy of CP-690,550 in Renal Allograft Recipients

Project: Research project

Project Details

StatusFinished
Effective start/end date12/12/0812/11/15

Funding

  • ICON Clinical Research, LLC (A3921050)
  • Pfizer Inc. (A3921050)